45272 Federal Register / Vol. 62, No. 165 / Tuesday, August 26, 1997 / Notices

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34 (a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: July 22, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22560 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated April 8, 1997, and

published in the Federal Register on

April 29, 1997, (62 FR 23268), Celgene

Corporation, 7 Powder Horn Drive,

Warren, New Jersey 07059, made

application by letter to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

4-Methoxyamphetamine (7411) a basic

class of controlled substance listed

Schedule I.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Celgene Corporation to

manufacture 4-Methoxyamphetamine is

consistent with the public interest at

this time. Therefore, pursuant to 21

U.S.C. § 823 and 28 C.F.R. §§ 0.100 and

0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated: July 29, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22561 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated March 31, 1997, and

published in the Federal Register on

May 8, 1997 (62 FR 25209), Ganes

Chemicals, Inc., Industrial Park Road,

Pennsville, New Jersey 08070, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Methylphenidate (1724) ................ II

Amobarbital (2125) ....................... II

Pentobarbital (2270) ..................... II

Secobarbital (2315) ...................... II

Glutethimide (2550) ...................... II

Methadone (9250) ........................ II

Methadone-intermediate (9254) ... II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Ganes Chemicals, Inc. to

manufacture the listed controlled

substances is consistent with the public

interest at this time. Therefore, pursuant

to 21 U.S.C. § 823 and 28 C.F.R. §§ 0.100

and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: July 29, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22562 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated February 26, 1997,

and published in the Federal Register

on March 19, 1997, (62 FR 13170),

Mallinckrodt Chemical, Inc.,

Mallinckrodt & Second Streets, St.

Louis, Missouri 63147, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ...... I

Methylphenidate (1724) ................ II

Cocaine (9041) ............................. II

Codeine (9050) ............................. II

Diprenorphine (9058) .................... II

Etorphine Hydrochloride (9059) ... II

Dihydrocodeine (9120) ................. II

Oxycodone (9143) ........................ II

Hydromorphone (9150) ................ II

Diphenoxylate (9170) ................... II

Hydrocodone (9193) ..................... II

Levorphanol (9220) ...................... II

Drug Schedule

Meperidine (9230) ........................ II

Methadone (9250) ........................ II

Methadone-intermediate (9254) ... II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

Morphine (9300) ........................... II

Thebaine (9333) ........................... II

Opium extracts (9610) .................. II

Opium fluid extract (9620) ............ II

Opium tincture (9630) ................... II

Opium powdered (9636) ............... II

Opium granulated (9640) ............. II

Levo-alphacetylmethadol (9648) .. II

Oxymorphone (9652) .................... II

Noroxymorphone (9668) ............... II

Alfentanil (9737) ........................... II

Sufentanil (9740) .......................... II

Fentanyl (9801) ............................ II

DEA has considered the factors in

Title 21, United States Code, Section

823(a), as well as information provided

by other bulk manufacturers, and

determined that the registration of

Mallinckrodt Chemical, Inc. to

manufacture the listed controlled

substances is consistent with the public

interest at this time. Therefore, pursuant

to 21 U.S.C. § 823 and 28 C.F.R. §§ 0.100

and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated July 28, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22563 Filed 8–25–97; 8:45 am]

Billing Code 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to Section 1301.33 of Title

21 of the Code of Federal Regulations

(CFR), this is notice that on July 10,

1997, Novartis Pharmaceutical Corp., 59

Route 10, East Hanover, New Jersey

07936, made application by letter dated

July 10, 1997, to the Drug Enforcement

Administration (DEA) for registration as

a bulk manufacturer of the Schedule II

controlled substance methylphenidate

(1724).

The firm, which is currently

registered with DEA as a bulk

manufacturer of methylphenidate at

another location plans to manufacture

validation batches in preparation of